REDWOOD SHORES, CA — (Marketwired) — 11/06/14 — Oracle (NYSE: ORCL)
Contract research organizations (CROs) are constantly looking to improve clinical trial data quality while reducing costs and accelerating studies for sponsors. They also seek ways to distinguish themselves in an increasingly competitive market. , one of China–s leading CROs, selected Oracle Health Sciences e-clinical solutions to help it advance each of these goals. Using the solutions, the CRO is improving clinical study efficiency and productivity and enhancing data accuracy, visibility, and integrity while credentialing itself with world-class e-clinical applications that boost sponsor confidence.
Guangzhou Boji, one of China–s leading CROs, implemented Oracle Health Sciences e-clinical solutions — including , and — to help improve clinical trial data quality, study efficiency, and productivity while reducing costs and accelerating studies for sponsors. Guangzhou Boji selected the Oracle Health Sciences e-clinical solutions in November 2013.
Guangzhou Boji, which conducts 40 to 50 key clinical trials a year from Phase I through Phase IV, replaced its legacy proprietary electronic data capture solution with Oracle Clinical and Oracle Remote Data Capture — helping to eliminate labor-intensive paper-based processes and data silos; accelerate data capture, validation, and submission; minimize manual data entry errors; and reduce paper use.
By automating and streamlining clinical trial processes, Guangzhou Boji is speeding data collection and time to database lock while reducing costs, elevating the value that it delivers to trial sponsors.
The CRO also plans to implement Oracle–s to help streamline its internal processes. With a centralized system to manage multiple studies, Guangzhou Boji hopes to lower trial costs and clinical research associate costs and to move toward paperless reporting.
“Oracle Health Sciences is known worldwide for its industry-leading e-clinical solutions, which help trial sponsors and CROs improve clinical study productivity and data quality while driving down operational costs. Oracle Health Sciences e-clinical applications, the industry gold standard, enable us to deliver greater value to our clients while fortifying their confidence in our organization. These factors are instrumental to our continued growth,” said Zhu Quan, data management director, Guangzhou Boji.
“Oracle Health Sciences e-clinical solutions are designed to help innovative organizations, such as Guangzhou Boji, achieve new levels of clinical development program productivity and efficiency. This relationship will bring opportunities for both Oracle and Guangzhou Boji to enhance clinical trial programs across Asia and provide high-quality trials in a growing market with more complex studies,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences.
Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle (NYSE: ORCL), visit .
Oracle industry solutions leverage the company–s best-in-class portfolio of products to address complex business processes relevant to health sciences, helping speed time to market, reduce costs, and gain a competitive edge.
At Oracle, we believe that a more predictive, preventive, personalized and participatory system will help improve human health. We can help accelerate this journey to personalized medicine through technology, data and insights. Oracle–s solutions support industry initiatives to improve care quality and outcomes, reduce costs, and speed time to market for new treatments, therapies and devices. Oracle Health Sciences delivers comprehensive business applications, plus database, middleware, and hardware solutions for life sciences and healthcare companies and institutions worldwide. For more information, visit .
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.
Samantha Thai
Oracle
+1.510.917.5564
Mary Tobin
O–Keeffe & Company
+1.503.658.7396
You must be logged in to post a comment Login